• Search
TheAHSNNetwork
  • Health and care reset
    • Health and care reset
    • Coronavirus (COVID-19)
  • Our work
    • National programmes
      • Blood Pressure Optimisation Programme
      • Polypharmacy Programme: getting the balance right
      • Eating disorders
      • ADHD diagnosis
      • Cardiovascular disease
      • Wound care
      • Insights prioritisation programme
    • Patient safety
    • Legacy programmes
    • New treatments and diagnostics (AAC)
    • Supporting innovators
    • Underpinning themes
      • Diversity in health innovation
      • Patient and public involvement
      • Sustainability and the environment
  • Latest
    • News
    • Blogs
    • Events
    • Newsletters
    • Podcasts
  • Resources
  • Atlas
  • About us
    • About us
    • Our people
    • Careers
  • Contact us
Home / AHSN Network / Transforming ADHD diagnosis
FOCUS, Transforming ADHD Diagnosis
Share
5 October 2020

Transforming ADHD diagnosis

Attention deficit hyperactivity disorder (ADHD) is a behavioural disorder that includes symptoms such as inattentiveness, hyperactivity and impulsiveness and affects around 5% of school-aged children worldwide. In the UK children can wait on average 18 months from their first appointment to receiving a formal ADHD diagnosis. The annual cost of ADHD assessments to the NHS is estimated at around £23m.

The Academic Health Science Network’s Focus ADHD intervention uses technology created by international health technology company Qbtech Ltd. The technology, QbTest, measures a patient’s attention, impulsivity and motor activity all at the same time. These indicators are core symptoms of ADHD and accurate measurement adds objectivity to support timely diagnosis.

The intervention has been selected following a demonstrator project across seven NHS sites in the East Midlands which showed a reduction in time to diagnosis by an average of 153 days. Using this intervention was also shown to increase staff capacity by reducing the number of appointments needed for diagnosis and by ruling out ADHD sooner for ambiguous cases. Releasing capacity of clinicians can help reduce waiting lists, improve treatment and allow more time to concentrate on complex cases.

With the support of the AHSNs, QbTest has already spread to 41 NHS trusts and 73 sites in England (June 20), but following a selection process which required robust evaluation and results, the intervention will be given further resources and support to spread across a much wider area – with the potential to reach a much larger amount of children and families.

The AHSNs are tasked with evaluating and spreading proven innovations that answer some of the country’s most pressing health and care challenges – the Focus ADHD initiative is an example of this. As outlined in the NHS Long Term Plan, published in January 2019, there is a commitment by the NHS to improve children and young people’s mental health services which includes reducing waiting times for specialist services and supporting children, young people and their families through the diagnostic process.

Find out more about the AHSN Network national programme.

GET THE LATEST HEALTH INNOVATION NEWS STRAIGHT TO YOUR INBOX

Sign up to our monthly newsletter, AHSN Network News, looking at the latest health innovation news, events, publications and opinion from across the AHSN Network.
Subscribe
AHSN Network East Midlands AHSN News Feed


Consensus pathway is blueprint for better outcomes for people with uncontrolled asthma
News
How AHSNs support the Government’s life sciences vision
Blog
TheAHSNNetwork
  • Contact us
  • Terms
  • Privacy
Copyright 2019 AHSN Network
  • Health and care reset
    • Health and care reset
    • Coronavirus (COVID-19)
  • Our work
    • National programmes
      • Blood Pressure Optimisation Programme
      • Polypharmacy Programme: getting the balance right
      • Eating disorders
      • ADHD diagnosis
      • Cardiovascular disease
      • Wound care
      • Insights prioritisation programme
    • Patient safety
    • Legacy programmes
    • New treatments and diagnostics (AAC)
    • Supporting innovators
    • Underpinning themes
      • Diversity in health innovation
      • Patient and public involvement
      • Sustainability and the environment
  • Latest
    • News
    • Blogs
    • Events
    • Newsletters
    • Podcasts
  • Resources
  • Atlas
  • About us
    • About us
    • Our people
    • Careers
  • Contact us
We use cookies, just to track visits to our website, we store no personal details. Accept Cookies What are cookies?
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
SAVE & ACCEPT